Pricing Log in Create free account
Saturday 17 October 2026 Export RMD’s income statement to Excel — free account

ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

238.97 3.26 −1.35%
Market cap
$34.1B
P/E
22.8×
Fwd P/E
16.6×
Dividend yield
1.03%
F-score
6/9
Altman Z
10.00
Beneish M
−2.59
Dividend safety
96/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

ResMed Inc. (RMD) EPS (diluted)

Alert me on EPS (diluted)

ResMed Inc.'s EPS (diluted) for fiscal 2026 was $10.43, up 9.67% from $9.51 in fiscal 2025. Over the past ten years it has ranged from $2.19 (fiscal 2018) to $10.43 (fiscal 2026) — the current reading is the highest in ten years. EPS (diluted) has risen for 5 consecutive fiscal years. ResMed Inc. ranks 1st of 49 Medical Instruments & Supplies companies by EPS (diluted).

EPS (diluted), annual

Embed this chart

Annual newest first

Period EPS (diluted) Change
FY2026 $10.43 9.67%
FY2025 $9.51 37.43%
FY2024 $6.92 13.63%
FY2023 $6.09 14.91%
FY2022 $5.30 63.58%
FY2021 $3.24 (24.12%)
FY2020 $4.27 52.50%
FY2019 $2.80 27.85%
FY2018 $2.19 (8.75%)
FY2017 $2.40 (3.61%)

Quarterly newest first

Period EPS (diluted) Change
Jun 2026 $2.64 (3.65%)
Mar 2026 $2.74 2.24%
Dec 2025 $2.68 13.08%
Sep 2025 $2.37 (8.14%)
42 more quarters

Against its own ten years

Low $2.19 High $10.43
Ten-year median $3.76
Current reading's percentile 100

EPS (diluted) against peers

Company EPS (diluted)
RMD ResMed Inc. $10.43
SOLV Solventum Corporation compare $8.18
WST West Pharmaceutical Services, Inc. compare $7.81
BDX Becton, Dickinson and Company compare $3.32
COO The Cooper Companies, Inc. compare $2.93
ALC Alcon compare $1.31
RGEN Repligen Corporation compare $0.73
BAX Baxter International Inc. compare −$2.07
MDLN Medline Inc. compare —

What EPS (diluted) is

Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.

Reported line item

The full definition of EPS (diluted) →

More on RMD